glp-1 menus All about GLP-1! Whether you're taking a medication or not The Ultimate Guide to GLP-1:

The symptoms are usually most pronounced during the first few weeks of treatment and following dose increases, generally improving as your body adapts to the medication

Additionally, the potential long-term benefits of GLP-1 therapy on different stages of cognitive impairment, such as MCI and dementia, warrant further exploration

60 Although modest at the individual level, a 5 mm Hg SBP reduction has been associated with about a 10% lower risk of major cardiovascular events, including 13% reductions in both stroke and heart failure, 8% in ischemic heart disease, and 5% in cardiovascular death, making these effects important at a population level

Semaglutide (Wegovy) and tirzepatide (Zepbound) have demonstrated significant average weight loss14.9% and 20.9% of body weight at approximately one year, respectively

What might make a difference is your dosage

Huang, J